Varicella zoster virus the ACIP recommended a second dose of vaccine before school entry to ensure the maintenance of high levels of varicella immunity. In 2006, the United States Food and Drug Administration approved Zostavax for the prevention of shingles. Zostavax is a more concentrated formulation of the Varivax vaccine, designed to elicit an immune response in older adults whose immunity to VZV wanes with advancing age. A systematic review by the Cochrane Library shows that Zostavax reduces the incidence of shingles by almost 50%. Shingrix is a "V. zoster" vaccine developed by GlaxoSmithKline which was approved in the United States by the
European Association for Technical Communication represent their interests on European level. tekom Europe supports important EU policies such as improving the training of young people, the employability and mobility of workers as well as the competitiveness of the European economy in general. One of the European initiatives which tekom Europe is involved in is ESCO (European Skills/Competences, qualifications and Occupations). The association currently consists of members from nine countries: Candidate Countries (where a country organization will be founded soon): tekom Europe's mission is to: European Association for Technical Communication The European Association for Technical Communication (tekom Europe e.V.) is the largest professional association for technical